Research & Innovation
Publications

Durvalumab after Sequential High Dose Chemoradiotherapy versus Standard of Care (SoC) for Stage III NSCLC: A Bi-Centric Trospective Comparison Focusing on Pulmonary Toxicity.

#2022

#Cancers

PMU Authors
Romana Wass, Brane Grambozov, Felix Sedlmayer, Michael Studnicka, Franz Zehentmayr

All Authors
Romana Wass, Maximilian Hochmair, Bernhard Kaiser, Brane Grambozov, Petra Feurstein, Gertraud Weiß, Raphaela Moosbrugger, Felix Sedlmayer, Bernd Lamprecht, Michael Studnicka, Franz Zehentmayr

Journal association
Cancers

Abstract

Keywords

SURVIVAL, RADIOTHERAPY, CONSOLIDATION, CHEMORADIATION, PHASE-III, CELL LUNG-CANCER, CONCURRENT, INHIBITOR-RELATED PNEUMONITIS, REAL-WORLD DATA, RTOG 0617

Latest Publication

#2026

#Original Article

Dana Macejova, Jakub Kollar, Zdenek Dvorak, Daniela Schuster, Julius Brtko Tributyltin propionate and tributyltin salicylate represent novel RXR ligands, Retinoid X receptor ligands; Thyroid hormone receptors; Transcriptional activity; Tributyltin propionate; Tributyltin salicylate; Vitamin D(3)receptor;

#2025

#Abstract

Valentin Fischill-Neudeck, Antje van der Zee-Neuen, Margitta B. Beil-Hildebrand Strengthening Professional Health Literacy: A Theory-Based Approach to Empower Nursing Practice

#2025

#Original Article

Benno Littger, Stefan Lorenzl, Sarah Bublitz, Thomas Hagen, Regina Sachse Forschungs- und Praxisprojekt: Spezialisierte Seelsorge in der Neurologie - SpeS Neuro

Back to Overview

Paracelsus Medical University (PMU) Research & Innovation Publications

Durvalumab after Sequential High Dose...